Incidence of Leukopenia in Ketogenic diet: A single-center experience (1446)

Objective: This study explores the incidence of leukopenia while adhering to one of the ketogenic diet therapies. Background: Ketogenic diet therapies have been shown to be an effective treatment for epilepsy in children and adults. Current consensus guidelines recommend that lab work be completed prior to diet initiation, and then every three months during the first year on diet; this includes a CBC with platelets. Design/Methods: A retrospective study was conducted on pediatric charts (age Results: Out of 79 pediatric patients who started on one of the ketogenic diet therapies, 12 patients were found to be leukopenic after diet initiation. 11 of 12 patients had a pre-diet CBC available for comparison. All patients with available pre-diet bloodwork were noted to have a decrease in leukocytes after diet initiation. None of the patients who developed leukopenia required extra precautions/changes in management. All 6 out of 12 patients who have been since weaned off diet have had improvement/normalization of labs. Conclusions: Routine labwork remains a key component of ketogenic diet monitoring. The population studied showed that 15% of patients demonstrated leukopenia as a direct result of the ketogenic diet. Development of leukopenia after diet initiation may lead to further testing/medical follow-up that does not necessarily warrant medical intervention. Further review of current practice guidelines is needed to determine the cost/benefit analysis of specific laboratory panels if no intervention is performed. Disclosure: Dr. Segal has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eisai, Lundbeck, Nurticia, Novartis, Greenwich; Consultant: Greenwich, Epitel, Encoded Therapeutics, Qbiomed. Dr. Paolicchi has nothing to disclose. Dr. Feoli has nothing to disclose. Dr. Dvorak has nothing to disclose. Dr. Amorese has nothing to disclose.